2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
- PMID: 27273869
- DOI: 10.1111/ajt.13909
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection
Abstract
The Banff Working Group on Liver Allograft Pathology reviewed and discussed literature evidence regarding antibody-mediated liver allograft rejection at the 11th (Paris, France, June 5-10, 2011), 12th (Comandatuba, Brazil, August 19-23, 2013), and 13th (Vancouver, British Columbia, Canada, October 5-10, 2015) meetings of the Banff Conference on Allograft Pathology. Discussion continued online. The primary goal was to introduce guidelines and consensus criteria for the diagnosis of liver allograft antibody-mediated rejection and provide a comprehensive update of all Banff Schema recommendations. Included are new recommendations for complement component 4d tissue staining and interpretation, staging liver allograft fibrosis, and findings related to immunosuppression minimization. In an effort to create a single reference document, previous unchanged criteria are also included.
Keywords: classification systems: Banff classification; clinical research/practice; guidelines; immunosuppression/immune modulation; liver transplantation/hepatology; rejection: T cell mediated (TCMR); rejection: antibody-mediated (ABMR); tolerance.
© Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.
Comment in
-
Antibody-Mediated Injury to the Transplanted Liver: Receiving the Sages' Wisdom.Am J Transplant. 2016 Oct;16(10):2773-2774. doi: 10.1111/ajt.13954. Epub 2016 Aug 1. Am J Transplant. 2016. PMID: 27389047 No abstract available.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
